SCOTT EDMONDSON
Senior Vice President Nimbus Therapeutics
Seminars
Wednesday 28th January 2026
Panel Discussion: How Do We Move Molecular Glues from Serendipity to Strategy While Overcoming Discovery Challenges?
2:00 pm
- From serendipity to platforms: Transitioning molecular glues from accidental findings to systematic discovery pipelines with scalable screening and validation strategies
- Beyond degradation: Exploring non-degrading molecular glues that stabilize or reprogram protein-protein interactions to modulate function
- Therapeutic reach: Applying molecular glues across oncology, immunology and neurology to leverage context-specific mechanisms and previously intractable targets
